Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective

A Kumar, AK Singh, H Singh, V Vijayan, D Kumar… - Pharmaceuticals, 2023 - mdpi.com
Cancer is one of the major healthcare challenges across the globe. Several anticancer
drugs are available on the market but they either lack specificity or have poor safety, severe …

Targeting cyclin-dependent kinase 2 CDK2: Insights from Molecular Docking and Dynamics Simulation-A systematic computational approach to discover novel cancer …

BK Chagaleti, BS Kumar, R Rajagopal… - … Biology and Chemistry, 2024 - Elsevier
Global public health is confronted with significant challenges due to the prevalence of
cancer and the emergence of treatment resistance. This work focuses on the identification of …

Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach

BK Chagaleti, V Saravanan, C Vellapandian… - RSC …, 2023 - pubs.rsc.org
Cancer prevalence and resistance issues in cancer treatment are a significant public health
concern globally. Among the existing strategies in cancer therapy, targeting cyclin …

New insights into the mechanisms of the extracellular matrix and its therapeutic potential in anaplastic thyroid carcinoma

J **a, Y Shi, X Chen - Scientific Reports, 2024 - nature.com
Anaplastic thyroid carcinoma (ATC) is the most aggressive thyroid cancer, and it has a poor
prognosis and high probability of metastatic recurrence. The long-term survival of cancer …

High-expressed PTPN1 promotes tumor proliferation signature in human hepatocellular carcinoma

L **e, H Qi, W Tian, S Bu, Z Wu, H Wang - Heliyon, 2023 - cell.com
Hepatocellular carcinoma (HCC) is a highly prevalent malignant tumor that is associated
with substantial morbidity and mortality rates. Despite the progress made in diagnostic …

Exploring the antiproliferative and proapoptotic activities of new pyridopyrimidine derivatives and their analogs

HM Ali, MA Said, S Allam, HA Abdel-Aziz… - Bioorganic & Medicinal …, 2025 - Elsevier
This study investigates a series of newly synthesized compounds, including
pyridopyrimidine derivatives (9a-g), tricyclic pyridotriazolopyrimidine analogs (18a-d), and …

Correlation analysis of disulfidptosis-related gene signatures with clinical prognosis and immunotherapy response in sarcoma

J Xu, K Guo, X Sheng, Y Huang, X Wang, J Dong… - Scientific Reports, 2024 - nature.com
Disulfidptosis, a newly discovered type of programmed cell death, could be a mechanism of
cell death controlled by SLC7A11. This could be closely associated with tumor development …

Medicinal chemistry perspective of pyrido [2, 3-d] pyrimidines as anticancer agents

A Kumar, KK Bhagat, AK Singh, H Singh, T Angre… - RSC …, 2023 - pubs.rsc.org
Cancer is a major cause of deaths across the globe due to chemoresistance and lack of
selective chemotherapy. Pyrido [2, 3-d] pyrimidine is an emerging scaffold in medicinal …

Decellularized tissues as platforms for digestive system cancer models

Z Seifi, M Khazaei, D Cheraghali, L Rezakhani - Heliyon, 2024 - cell.com
The extracellular matrix (ECM) is a multifunctional network of macromolecules that regulate
various cellular functions and physically support the tissues. Besides physiological …

Semisynthetic phytochemicals in cancer treatment: a medicinal chemistry perspective

M Arora, AK Singh, A Kumar, H Singh… - RSC Medicinal …, 2024 - pubs.rsc.org
Cancer is the uncontrolled proliferation of abnormal cells that invade other areas, spread to
other organs, and cause metastases, which is the most common cause of death. A review of …